New research from the Minneapolis Heart Institute Foundation has uncovered a way to help interventional cardiologists better predict which patients are at higher risk for death following TAVR, allowing both patient and surgeon to discuss a potentially different treatment plan.

 

According to a new long-term study, diabetic patients with even mild coronary artery disease face the same relative risk for a heart attack or other major adverse heart events as diabetics with serious single-vessel obstructive disease.

Results from a new study indicate that the addition of mitral valve (MV) repair to coronary artery bypass grafting (CABG) did not result in significant benefit to the patient and was associated with increased risk of neurological events. Therefore, the routine addition of MV repair to CABG in patients with moderate ischemic mitral regurgitation (IMR) did not demonstrate a clinically meaningful advantage.

Fatigue, increased irritability and feeling demoralized may raise a healthy man or woman’s risk of first-time cardiovascular disease by 36 percent, according to a study led by researchers at Mount Sinai St. Luke’s and Mount Sinai Roosevelt hospitals. Study results were presented on Nov. 17 at the American Heart Association’s Scientific Sessions 2014 in Chicago.

Medi?Lynx Cardiac Monitoring LLC and MEDICALgorithmics will participate in a research project, investigating the impact of lifestyle modification on ablation outcome in atrial fibrillation (ISOLATE). The research is financed by Texas Cardiac Arrhythmia Research Foundation. The PocketECG cardiac monitoring system will be used for collecting and analyzing the ECG data in the project

Covidien announced that it received U.S. Food and Drug Administration 510(k) clearance for its Fortrex over-the-wire (OTW) percutaneous transluminal angioplasty (PTA) balloon catheter.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now